Navamedic Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 45


  • Stock Symbol
  • NAVA

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $3.48
  • (As of Friday Closing)

Navamedic General Information


Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Distributors (Healthcare)
Stock Exchange
Corporate Office
  • Henrik Ibsensgate 100
  • 0255 Oslo
  • Norway
+47 67 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Navamedic Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.48 $3.39 $2.89 - $4.17 $60.4M 17.4M 24K $0.12

Navamedic Financials Summary

In Thousands,
TTM 30-Jun-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 61,207 59,074 63,001 32,295
Revenue 44,022 39,541 32,286 22,180
EBITDA 4,023 4,892 1,019 (1,347)
Net Income 1,961 3,045 72 (1,739)
Total Assets 42,129 39,055 37,430 30,461
Total Debt 12,383 6,397 7,706 4,994
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Navamedic Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Navamedic‘s full profile, request access.

Request a free trial

Navamedic Comparisons

HQ Location
Total Raised
Post Valuation
Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributi
Oslo, Norway
45 As of 2023
000000000 000.00


uip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
Odense, Denmark
0000 As of 0000


consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolor
Bromma, Sweden
0 As of 0000
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Navamedic Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orifarm Group Corporation Odense, Denmark 0000
Moberg Pharma Corporation Bromma, Sweden 0 000.00 000000 - 000 000.00
axicorp Corporate Backed or Acquired Friedrichsdorf, Germany 000 000000&0
You’re viewing 3 of 3 competitors. Get the full list »

Navamedic Executive Team (10)

Name Title Board Seat Contact Info
Kathrine Andreassen Chief Executive Officer
Lars Hjarrand Chief Financial Officer
Ole Eriksen Chief Business Development Officer
Astrid Bratvedt Chief Scientific Officer
You’re viewing 4 of 10 executive team members. Get the full list »

Navamedic Board Members (4)

Name Representing Role Since
0000000 00000000 Self Board Member 000 0000
00000 000000 Reiten & Co Chairman 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Navamedic Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Navamedic Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Navamedic‘s full profile, request access.

Request a free trial

Navamedic Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sensidose 25-May-2023 0000000000 00.00 Other Devices and Supplies
Impolin 01-Jun-2022 0000000000 00.000 Distributors/Wholesale 00000000
Novicus Pharma 13-Feb-2019 0000000000 Pharmaceuticals 00000 000
Observe Medical 03-Aug-2015 0000000000 00.000 Monitoring Equipment 00000000
Vitaflo Scandinavia 05-Oct-2007 Merger/Acquisition 000.00 Pharmaceuticals
To view Navamedic’s complete acquisitions history, request access »

Navamedic Subsidiaries (3)

Company Name Industry Location Founded
Novicus Pharma Pharmaceuticals Oslo, Norway 2018
Impolin Distributors/Wholesale Taby, Sweden 0000
Vitaflo Scandinavia Pharmaceuticals Gothenburg, Sweden 0000
To view Navamedic’s complete subsidiaries history, request access »

Navamedic ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies











To view Navamedic’s complete esg history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »